
John Kinsella
Director, Clinical Research · University of Colorado School of Medicine
Credentials: · ·
History
- Present
Clinical Research · University of Colorado School of Medicine
- Present
- 1983–1986
Pediatrics
- 1975–1979
Research
Circulation · 2015 · 859 citations
Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn
The Lancet · 1992 · First of 4 authors · 613 citations
New England Journal of Medicine · 2000 · Last of 9 authors · 534 citations

117 papers
- DI
38 papers

27 papers

20 papers

11 papers · 11 as a fellow

11 papers
- DG
9 papers

9 papers
Grants
- 2010–2013
Phase II Trial of Sildenafil in Newborns with Persistent Pulmonary Hyptertension
National Heart, Lung, and Blood Institute · U01
Contact PI · $1.3M · University of Colorado Denver
- 2006–2012
Lung Vascular Disease in Infants and Children: Mechanisms and Treatment
National Heart, Lung, and Blood Institute · P50
Project lead · $2.3M · University of Colorado Denver
- 2000–2008
Inhaled No for the Prevention of Chronic Lung Disease
National Heart, Lung, and Blood Institute · U01
Contact PI · $8.2M · University of Colorado Denver
- 1997–2008
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $508.5K · University of Colorado Denver
Clinical trials
- 2017–2022
Registry of Preterm Newborns With Severe Pulmonary Hypertension
Principal investigator · Completed
University of Colorado, Denver
- 2011–2013
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Principal investigator · Terminated · Phase 2
University of Colorado, Denver
- 2007–2014
Principal investigator · Completed · Phase 2
University of Colorado, Denver
- 2000–2007
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Study chair · Completed · Phase 3
University of Colorado, Denver

